Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.27
0.07 (0.07%)
At close: Aug 14, 2025, 3:59 PM
105.00
-0.26%
Pre-market: Aug 15, 2025, 04:25 AM EDT
0.07% (1D)
| Bid | 100 |
| Market Cap | 8.95B |
| Revenue (ttm) | 118.53M |
| Net Income (ttm) | -164.02M |
| EPS (ttm) | -1.04 |
| PE Ratio (ttm) | -101.22 |
| Forward PE | 118.3 |
| Analyst | Hold |
| Ask | 105.38 |
| Volume | 1,295,668 |
| Avg. Volume (20D) | 3,498,346 |
| Open | 105.25 |
| Previous Close | 105.20 |
| Day's Range | 105.21 - 105.33 |
| 52-Week Range | 24.50 - 105.50 |
| Beta | 0.12 |
About VRNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Verona Pharma is scheduled to release its earnings on
Nov 3, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+20.62%
Verona Pharma shares are trading higher after Merc...
Unlock content with
Pro Subscription
2 months ago
+3.77%
Verona Pharma shares are trading higher after Jefferies raised its price target on the stock from $95 to $110. Also, Cantor Fitzgerald raised its price target on the stock from $90 to $100.
